我武生物：上海利合因违规减持需返还超千万，医旭医疗承担连带责任

Core Viewpoint - The company announced a lawsuit progress regarding a breach of commitment related to stock reduction by Shanghai Lihui Equity Investment Partnership (Limited Partnership) [1] Group 1 - The court made a first-instance judgment on October 31, 2025, ordering the defendant, Shanghai Lihui Equity Investment Partnership (Limited Partnership), to return 10.96 million yuan and pay related interest [1] - Shanghai Yixu Medical Technology Co., Ltd. is jointly liable for the judgment [1] - As of the announcement date, the case is within the appeal period for the first-instance judgment, which has not yet taken effect [1]